CHARAC SECURES INVESTMENT FROM PRIVATE EQUITY FIRM TRADITUM TO ACCELERATE ITS GROWTH IN THE UK MARKET AND INTERNATIONALLY
Summary
This has been achieved through various strategic partnerships, including with leading PMR software provider, Positive Solutions and the National Pharmacy Association. This leaves pharmacists unable to capitalise on the efficiencies that digitisation can deliver and not capable of delivering the broader range of revenue-enhancing services that can boost their profits.The benefits of repositioning the role of the pharmacy are vast according to insights from EY, 2.1 million additional primary care appointments could be generated in the UK every week. Also, given the \xa3645 million NHS investment planned for community pharmacy services, the potential for Characs further growth is very positive.The UK the retail pharmacy market is projected to grow from around \xa321 billion in 2022 to \xa331 billion by 2030.Traditum brings together high-net worth individuals with carefully-selected UK companies to offer tax-efficient investment opportunities. Its existing healthtech investments include health and lifestyle coaching platform Added Health, Scotlands first medicinal cannabis facility Hilltop Leaf and nurse call systems specialist Arquella.Santosh Sahu, founder and CEO of Charac, said: The investment from Traditum is an endorsement of our mission to transform independent pharmacies through digitising the sector. With this backing we are positioned to expand our international reach as well as our capabilities to enhance the quality of care our customers can provide to patients.David Mitchell, CEO of Traditum, said: Independent pharmacies are facing a real challenge.